Switching Disease-Modifying Therapies from Sphingosine-1-phosphate Receptor Modulators to Natalizumab or Dimethyl Fumarate Restores Immune Responses after SARS-CoV-2 Mrna Vaccination in Patients with Multiple Sclerosis
CLINICAL NEUROLOGY AND NEUROSURGERY（2024）
Key words
SARS-CoV-2,mRNA vaccine,Multiple sclerosis,Fingolimod,Siponimod
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined